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Edited by Lev KisslevAbstract We have shown that ElrA and ElrB, Xenopus ELAV
homologues, bind the Vg1 mRNA 3 0UTR translation element in
Xenopus oocytes and implicated ElrB in mediating translational
repression during oogenesis. Here we report that, while ElrA and
ElrB are 69% identical and both exhibit RNA binding in the nM
range, recombinant ElrB, but not ElrA, is able to oligomerise.
This oligomerisation is also seen with the endogenous protein.
Both RNA binding and oligomerisation require the linker region
ﬂanked with two RNA recognition motifs. Our data demonstrate
a novel and unique property of ElrB which may be important for
its function as a translational regulator.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The ELAV-like proteins are RNA-binding proteins named
after the ﬁrst member, ELAV (embryonic lethal abnormal vi-
sion), identiﬁed in Drosophila [1]. In vertebrates, the ELAV-
like family contains four members, ElrA, ElrB, ElrC and ElrD,
produced from diﬀerent genes [2]. In humans, the homologues
are named HuR, Hel-N1 (HuB), HuC and HuD. All the
ELAV proteins have a characteristic structure of three RNA
recognition motifs (RRMs) with RRM1 and RRM2 in tandem
followed by a linker region and a terminal RRM [3–6].
Although the RRMs are conserved amongst the ELAV family,
the N-terminus and the linker region are somewhat diverse [7].
Previous studies have shown that ELAV proteins interact
speciﬁcally with AU-rich elements (AREs) in the 3 0 untrans-
lated regions (UTRs) of various mRNAs [4,8–11] and they
have been implicated in key mechanisms of post-transcrip-
tional regulation including mRNA stability, translation and
alternative splicing [12–15]. A more recent study shows that
the translational repression of CAT-1 mRNA, which isAbbreviations: VTE, Vg1 translation element; VLE, Vg1 localisation
element; RRM, RNA recognition motif; ARE, AU-rich element;
UTR, untranslated region; rRNA, ribosomal RNA; Kd, dissociation
constant; RNP, ribonucleoprotein
*Corresponding author. Fax: +44 1223766002.
E-mail address: nms@mole.bio.cam.ac.uk (N. Standart).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.08.012mediated by the micro RNA miR-122, can be relieved by
HuR [16].
In Xenopus oocytes, only two ELAV proteins are expressed,
ElrA and ElrB, and both are found in the cytoplasm [3,17]. We
have previously shown that, during oogenesis, these two pro-
teins speciﬁcally bind the Vg1 translation element (VTE).
Vg1 encodes a protein involved in mesoderm induction and
the mRNA is both localised and translationally repressed dur-
ing oogenesis. The VTE is a 250 nt, AU-rich element, in the
3 0UTR of the Vg1 mRNA, which represses the translation of
a reporter RNA, both in vivo and in vitro, to the same extent
as the full length 3 0UTR [11]. The expression pattern of ElrB
during early oogenesis is most consistent with a role for ElrB,
rather than ElrA, in the translational control of Vg1 mRNA
[17]. Disruption of the consensus ElrB binding site in the
VTE abolished the repression of the reporter RNA while
multiple copies of this same binding site supported transla-
tional repression. Most importantly, injection of antibody
against ElrA and ElrB resulted in the synthesis of Vg1 protein
[17].
In this study, we show that recombinant ElrB, but not
ElrA, oligomerises, and that endogenous ElrB oligomerises
during the early stages of oogenesis when Vg1 mRNA trans-
lation is repressed [17]. We also determine that the oligomer-
isation of ElrB is RNA-dependent and requires the linker
region ﬂanked by two RRMs. The data suggest a speciﬁc abil-
ity of ElrB to oligomerise that may be functionally relevant
in vivo.2. Materials and methods
2.1. Cloning of recombinant proteins
Constructs containing the Xenopus ElrA and ElrB coding regions
were kindly provided by Peter Good (Accession Nos. U17596.1 and
U17597.1, respectively). The coding sequences for the full-length pro-
teins and the subdomains were ampliﬁed by PCR. The primers were de-
signed to introduce an NcoI site at the 5 0-end and an XhoI site at the 3 0-
end. These sites were used to insert the PCR products into the vector
pGIT [18] to allow the expression of C-terminally His-tagged proteins.
The forward primer for ElrA was 5 0-TGCCATGGGTAAC-
GGTTATGAAGATCAC-3 0, the reverse primer was 5 0-TTGCGG-
CCGCCCTCGAGTTTGTGTGACTT-3 0. The forward primer for
ElrB, B1, B12 and B12L was 5 0-TGCCATGGCAGTCAGACTG-
TGTGAT-3 0; B2 and B2L3 was 5 0-TGCCATGGGTTCGGCATCAA-
TAAGGGAT-3 0; B3 was 5 0-TGCCATGGGACATGCTGGTACAG-
GATGG-30. The reverse primer for ElrB, B2L3, and B3 was 5 0-
TTGCGGCCGCCCTCGAGAGCTTTGTGTGTTTT-3 0; B12L and
B2L was 5 0-TTGCGGCCGCCCTCGAGAAAGTTAATCCCAGC-
CAAAC-30; B12 and B2 was 5 0-TTGCGGCCGCCCTCGAGATTGT-
TGGCAAACTTCACCG-3 0; B1 was 5 0-TTGCGGCCGCCCTCG-
AGTCTGGCATAGGATACTTTAA-3 0.blished by Elsevier B.V. All rights reserved.
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Escherichia coli
Chemically-competent BL21 star (DE3) cells (Novagen) were elec-
troporated with the appropriate plasmids. The cells were grown in
2·TY at 37 C to an A600 of 0.4 and induced with 1 mM IPTG for
3 h at 37 C. Following centrifugation, the cell pellets were resus-
pended in 25 ml HNTA (1 M NaCl, 50 mM sodium phosphate buﬀer,
pH 7.8, 1% Triton X-100) supplemented with 2· Complete Protease
Inhibitors (Roche), 2 mM benzamidine and 3.5 mM b-mercap-
toethanol and the cells lysed using a French press. Following centrifu-
gation, the soluble fractions were mixed with 1 ml of HNTA-
equilibrated Ni-NTA resin (Qiagen) and incubated at 4 C with rota-
tion for a minimum of 1 h. The beads were washed consecutively with
HNTA, PBS and PBS supplemented with 50 mM imidazole and then
the recombinant proteins were eluted oﬀ the Ni-NTA beads into
1 ml of PBS containing 1 M imidazole and passed through a PD10 col-
umn (Amersham) to exchange the buﬀer to protein buﬀer (150 mM
NaCl, 50 mM sodium phosphate buﬀer, pH 7.8, 1 mMDTT, 15% glyc-
erol, 0.1% Triton X-100). The concentrations of the His-tagged pro-
teins were determined by Bradford assay and by SDS–PAGE
analysis of protein dilutions against BSA standards.
2.3. Preparation of oocyte lysates
Mixed stage lysate was prepared as described in [11] while staged ly-
sate was prepared according to [19].
2.4. RNA synthesis
To generate a uniformly radiolabelled probe for ﬁlter binding and
band shift assays, 0.5 lg of linearised pVLE [17] and pVTE [11] were
used as a template for transcription by T7 RNA polymerase in the
presence of [a32P]-UTP as described [20]. All in vitro transcribed
mRNAs were puriﬁed by centrifugation through ProbeQuant G-50
Micro Columns (Amersham Biosciences) and quantitated after precip-
itation with CTAB.
2.5. Band shift assay
Binding reactions containing 100 mM KCl, 1 mg/ml heparin,
0.1 mg/ml competitor E. coli ribosomal RNA (rRNA), 2 ll Xenopus
extract and 10 fmol [32P]-labelled RNA in 1· Binding Buﬀer (10 mM
HEPES, pH 7.2, 3 mM MgCl2, 5% glycerol, 1 mM DTT) were incu-
bated at room temperature for 15 min. To detect a supershift, the reac-
tions were incubated for a further 5 min in the presence of protein A–
Sepharose puriﬁed antibody. After the addition of 2 ll of 30% glycerol,
samples were separated on a 5% non-denaturing gel and exposed to
Fuji Super RX X-ray ﬁlm overnight.Fig. 1. ElrB-VTE complexes diﬀer from ElrA–VTE complexes in gel retardat
equivalent of stage I or stage VI lysate mixed with 10 fmol [32P]-labelled VTE
immune serum (PI), 3 ll a-Vg1RBP and 0.5 ll a-HuR). The supershift obtain
and those obtained with a-ElrB antibody are indicated with black stars. (B) O
mixed with 10 fmol [32P]-labelled VLE probe and the indicated antibodies a2.6. Filter binding assay
The procedure was adapted from [21]. Reactions containing varying
concentrations of His-tagged recombinant protein (1–500 nM) and 1–
5 nM [32P]-labelled probe in 1· Filter Binding Buﬀer (100 mM KCl,
50 mM Tris, pH 8.0, 1 mMMgCl2) were incubated for 10 min at room
temperature. The samples were then ﬁltered through a Hybond-C
membrane (Amersham Biosciences) using a dot blot vacuum appara-
tus. Following three washes with Filter Binding Buﬀer, the mem-
brane-bound fraction of the probe was quantitated using a
PhosphorImager screen (Molecular Dynamics).
2.7. Ni-NTA Pull-down assay
Ten ll Ni-NTA beads were pre-incubated with 30 pmol His-tagged
recombinant protein in a ﬁnal volume of 200 ll Pull-down Buﬀer
(100 mM KCl, 1 mM MgCl2, 50 mM HEPES, pH 7.5, 5 mM imidaz-
ole, 0.2% NP-40, 5% glycerol) for 1 h at 4 C. After washing the beads,
10 ll [35S]-labelled protein, obtained by coupled transcription/transla-
tion [22], were added and incubated for 2 h at 4 C. Following wash-
ing, the bead-bound fractions were eluted with 30 ll 2· PSB and
resolved by SDS–PAGE.3. Results
3.1. ElrB–VTE complexes diﬀer from ElrA–VTE complexes in
supershift gel retardation assays
The level of expression of the two maternally expressed
Xenopus ELAV proteins diﬀers during oogenesis. While ElrA
increases between stages III and VI, ElrB, on the other hand,
is present in high amounts in early oocytes, stages I–III, when
Vg1 mRNA is translationally repressed. Vg1 translation is
activated from stage IV onwards [11] when the level of ElrB
dramatically decreases.
To compare ribonucleoprotein (RNP) complexes formed be-
tween the VTE and the two ELAV proteins during oogenesis,
we performed gel retardation assays with labelled VTE RNA
and an equivalent amount of lysate from stage I or VI oocytes
(Fig. 1A). Puriﬁed peptide antibodies speciﬁcally recognising
ElrA and ElrB were added to the staged lysates to detect the
association of the VTE with individual proteins. The addition
of the anti-ElrA antibody gives a single supershift with bothion assays. (A) Gel retardation assays were performed with one oocyte
probe and the antibodies indicated (2 ll a-ElrA, 5 ll a-ElrB, 3 ll pre-
ed upon the addition of a-ElrA antibody is indicated with a white star
ne microlitre of Xenopusmixed staged lysate (1 oocyte equivalent) was
s in (A).
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UV-cross linking data [11] indicating equal binding of ElrA to
the VTE throughout oogenesis. In contrast, the anti-ElrB anti-
body detects and supershifts a complex in stage I but not in
stage VI oocytes, reﬂecting the decreased level of ElrB in stage
VI relative to stage I oocytes [17].
More importantly, we noted that the anti-ElrB antibody re-
sults in at least three independent supershifted complexes likely
to represent the binding of multiple molecules of ElrB to the
VTE probe. In agreement, a-HuR antibody, which essentially
detects only ElrB in stage I oocytes, results in at least two
supershifted complexes. Preimmune antibody and an antibody
raised against Vg1RBP, which binds the Vg1 localisation
element (VLE) but not the VTE [11], did not supershift any
VTE-containing RNA (Fig. 1A). In contrast, anti-Vg1RBP
antibody, but not anti-ElrA or anti-ElrB antibody, induced a
shift in a VLE-containing complex (Fig. 1B). These controls
validate our hypothesis that endogenous ElrB, unlike ElrA,
may be present in multiple complexes when bound to the VTE.Fig. 2. Both recombinant ElrA and ElrB proteins have high aﬃnity
for RNA, but only ElrB oligomerises. (A) Filter binding experiments
were performed with 1, 2, 3, 4, 5, 10, 20, 50 and 100 nM ElrA and ElrB
bound to 30 fmol [32P]-labelled VTE probe in the absence of
competitors. The amount of RNA bound to protein and thus retained
on a nitrocellulose membrane was quantitated on a Phosphorimager
and plotted against protein concentration. The Kds for ElrA and ElrB
were determined by linear regression using the linear part of the curve
(between 1 and 5 nM). (B) Poly(A), poly(U) and poly(C) were used as
competitors at 10-, 100- or 1000-fold excess over the labelled VTE
probe in ﬁlter-binding reactions containing 20 mM recombinant
protein. The results are expressed as a percentage relative to the
binding in the absence of competitor. The experiment was performed
several times and the data shown are representative. (C) An increasing
amount (0, 25, 50, 100, 250, 500 nM) of recombinant ElrA and ElrB
were incubated with 10 fmol [32P]-labelled VTE and the reaction
resolved by native PAGE.3.2. Both ElrA and ElrB bind RNA eﬃciently
To investigate the RNA-binding properties of the two Xeno-
pus ELAV proteins, recombinant His-tagged versions were
puriﬁed after overexpression in E. coli. The dissociation con-
stants (Kd) of ElrA and ElrB binding to the VTE were deter-
mined using a ﬁlter-binding assay in the absence of
competitors. The Kd of ElrB was calculated to be approxi-
mately 3 nM (ranging from 1 to 4 nM) and that of ElrA to
be approximately 7 nM (ranging from 5 to 12 nM) (Fig. 2A).
Thus, both proteins bind to the RNA with high aﬃnity, with
Kds in the low nM range.
We have previously shown that the VTE possesses AU-rich
sequences at the 5 0- and 3 0-ends that are required for transla-
tional repression [11]. Here, poly(A), poly(U) and poly(C) were
used as competitors in the ﬁlter-binding assay (Fig. 2B). The
competitors were added individually to the reactions in 10-,
100- or 1000-fold molar excess over the labelled VTE RNA
probe. Only poly(U) completely abolished the binding of both
recombinant ElrA and ElrB to the VTE, even at the lowest
concentration, suggesting that the recombinant ElrA and ElrB
interact mainly with U residues.
The full-length recombinant proteins were also tested in a
band shift assay to examine possible diﬀerences in complex for-
mation (Fig. 2C). Interestingly, we noted that ElrB but not
ElrA, is able to oligomerise, as indicated by the extensive
smearing of the probe RNA. Therefore, the recombinant pro-
teins behave in a similar manner to endogenous ElrA and
ElrB.3.3. Determination of the domains responsible for ElrB RNA
binding
Diﬀerent subdomain combinations of ElrB (Fig. 3A) were
over-expressed as His-tagged forms in E. coli, puriﬁed
(Fig. 3B) and analysed by ﬁlter-binding assay to compare the
involvement of each of the RRMs in RNA binding
(Fig. 3C). Not all possible combinations of the subdomains
were obtainable, due to lack of expression, solubility or puriﬁ-
cation. The results show that the puriﬁed ElrB subdomains can
be divided into three categories. The ﬁrst category, comprising
B2 and B3, has a very low aﬃnity for the RNA
(Kd P 500 nM). The second category of subdomains (B1and B12) is able to bind the RNA (Kd  20 nM), but they
do not bind the RNA as well as the third category, which in-
cludes the full-length ElrB and the fragment B2L3
(Kd  3 nM).
Next, the ElrB subdomains were examined by band shift as-
say using the same RNA and recombinant proteins at 25 and
500 nM (Fig. 3D). The full-length protein, ElrB, binds the
VTE at a concentration of 25 nM (lane 2) and at 500 nM,
when a higher molecular weight shift due to oligomerisation
is observed (lane 3). The subdomains B1 and B12 both bind
the RNA with distinct shifted complexes seen above the free
probe (lanes 6 and 9), albeit with lower aﬃnity than the full-
length protein. In contrast, the single RRM fragments B2
and B3 do not shift the RNA probe, even at the highest protein
concentration (lanes 12 and 18). The only protein, in the set of
subdomains tested, capable of forming a high molecular
Fig. 3. The roles of individual ElrB subdomains in RNA binding by ﬁlter-binding and band shift assays (A) Schematic representation of the puriﬁed
subdomains of ElrB protein. (B) Coomassie-stained SDS–PAGE of the puriﬁed subdomains. (C) Thirty fmoles [32P]-labelled VTE RNA were
incubated with an increasing concentration (0, 1, 2, 5, 10, 20, 50, 100 and 200 nM) of full-length recombinant ElrB and each of the puriﬁed
subdomains (B1, B12, B2, B2L3 and B3), in the absence of competitors and the reactions subjected to ﬁlter binding. The experiments were performed
in duplicate, then quantitated by PhosphorImager and the resulting values plotted. The Kd values for the full-length ElrB and each of the subdomains
were determined and shown in the table on the right. (D) Ten fmoles [32P]-labelled VTE were incubated with an increasing concentration of the
recombinant ElrB subdomains (0, 25 and 500 nM) in the presence of 0.1 mg/ml E. coli rRNA and analysed by native PAGE and autoradiography.
The migration of the free probe and of the shifted complexes are indicated on the left.
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15). Therefore, the two proteins that have the highest aﬃnity
for RNA, ElrB and B2L3, are also the two proteins that olig-
omerise, and are the only two proteins in the set of puriﬁed
ElrB subdomains that contain the linker region. These data
suggest that, in the case of ElrB, the linker region may be in-
volved both in RNA binding and in oligomerisation.
3.4. ElrB oligomerisation is RNA-dependent
To examine whether ElrB interacts with itself, and whether
such an interaction is direct or requires RNA, we used pull-
down assays performed with His-tagged recombinant ElrB
bound to Ni-NTA beads and labelled proteins synthesised in
rabbit reticulocyte lysate. In order to assay the dependence
of oligomerisation on the presence of RNA, the translation
reactions were treated with 1 mg/ml RNase A prior to incuba-
tion with ElrB-bound Ni-NTA beads (Fig. 4A). Fragments of
mRNA, rRNA and tRNA remain after the micrococcal nucle-
ase treatment of the lysate and these could mediate an RNA-
dependent interaction. ElrA was used as a control. Labelled
ElrA bound weakly and non-speciﬁcally to Sepharose and to
His-tagged ElrA and ElrB (lanes 4–9). In contrast, a strong
interaction between ElrB and itself (lane 17) was detected, aspreviously, but only in the absence of RNase treatment (lane
18). Therefore, the presence of RNA is necessary for the olig-
omerisation of ElrB.
3.5. Further study of the ElrB subdomains and the linker region
As the subdomains where the linker region was at the N- or
C-terminus could not be puriﬁed from E. coli, to examine the
role of the linker region in oligomerisation, pull-down assays
were performed with His-tagged recombinant ElrB and three
additional labelled ElrB subdomain variants (B12L, B2L and
BL3) synthesised in rabbit reticulocyte lysate.
Fig. 4B shows that only full-length ElrB (lane 4) and the sub-
domain B2L3 (lane 13) are able to self-associate. Subdomains
B12L and B2L are unable to interact with ElrB (lanes 7 and
10) suggesting that the linker alone is not responsible for the
oligomerisation of ElrB. BL3 appears to show some interac-
tion with ElrB (lane 17) but not to the same extent as full-
length ElrB (lane 4) or B2L3 (lane 13). These data suggest a
requirement for the linker region ﬂanked by 2 RRMs for eﬃ-
cient ElrB oligomerisation. In addition to the ElrB subdomains
tested, TIA-1 was used as a control. TIA-1 is another AU-rich
element-binding protein containing three RRMs that has pre-
viously been shown to play a role in the translational repres-
Fig. 4. Self-association of ElrB assessed by pull-down assay. (A) ElrA and ElrB were translated using the coupled transcription/translation system
and subjected to a pull-down assay. RNase-treated (+) and non-treated () proteins were mixed with 2 lg full-length His-tagged recombinant ElrB or
ElrA pre-incubated with 10 ll of Ni-NTA beads or with beads alone. Protein size markers (M) are indicated on the right in kDa. (B) A schematic
representation of the subdomains of ElrB protein containing the linker region, obtained using the coupled transcription/translation system is shown
on the left. The proteins were translated in the presence of [35S]-methionine resulting in radiolabelled proteins (I) that were subjected to a pull-down
assay with Ni-NTA beads alone as a control (C) or with 2 lg of full-length His-tagged recombinant ElrB incubated with 10 ll beads (B). An
additional control is shown in the right-hand panel, where His-tagged TIA-1 replaced ElrB. The experiment was performed on three diﬀerent
occasions and the same results seen. Protein size markers (M) are indicated on the right in kDa.
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showed no interaction with ElrB (lane 20). These data conﬁrm
and extend those obtained in the band shift assays and to-
gether suggest that the linker region has to be ﬂanked by both
RRM2 and RRM3 for ElrB to bind RNA and to oligomerise.4. Discussion
The overall domain structure of ELAV proteins is composed
of three RRMs, with a linker sequence between RRM2 and
RRM3 (reviewed in [25]). The ELAV proteins, in particular
the RRM domains, are highly conserved between species and
between diﬀerent members of the family; for example, the hu-
man/Xenopus orthologs HuR/ElrA and HuB/ElrB are 92% and
93% identical, respectively, and ElrA/ElrB are 69% identical
overall. However, only 50% identity is observed in the linker
domain between ElrA and ElrB. ElrA/HuR possesses the
shortest linker region of 55 amino acids. The key diﬀerence
between the linker domain in ElrA and ElrB is the insertion
of 15 amino acids in ElrB [2,3].
In several studies addressing the question of which portions
of ELAV proteins are responsible for RNA binding, it is gen-erally agreed that RRM1 and RRM2 are the principal RNA-
binding domains in HuR, HuC and HuD [5,7,26], as well as in
ElrA and mHuC [27,8]. The role of RRM3 is less well-deﬁned.
RRM3 from HuC and HuD has been shown to bind poly(A)
[5,8], while the HuD RRM3 has also been described as enhanc-
ing RNA binding by RRM1 [28]. In the case of HelN1/HuB,
RRM3 on its own is capable of eﬃcient binding of c-myc
RNA [4]. These diﬀerences may reﬂect the use of diﬀerent as-
says to monitor RNA binding, the examination of diﬀerent
ELAV proteins and RNA targets and the diﬀerent subsets of
domains being compared. Nevertheless, there is broad agree-
ment that stronger binding generally occurs with two RRMs
[25]. Our results indicate that, for ElrB with our substrate,
highest aﬃnity binding is provided by RRM2-linker-RRM3.
Several investigators have observed that ELAV and ELAV-
like proteins are capable of oligomerisation [29,30,14]. In par-
ticular, HelN1/HuB was noted to undergo several band-shifts
in gel retardation assays [4]. However, no direct functional rel-
evance of the multimerisation has been described. We show
here that ElrB, but not ElrA, oligomerises, suggesting a role
for the linker domain in oligomerisation. Interestingly, a po-
tential role for the linker in oligomerisation of an ELAV-re-
lated RNA-binding protein, EDEN-BP, has been described
[29].
4952 A. Devaux et al. / FEBS Letters 580 (2006) 4947–4952Thus, we have shown that ElrB diﬀers signiﬁcantly from
ElrA in its ability to oligomerise. Key proteins, such as
FRGY2 and Xp54, which are involved in the formation of
translationally repressed mRNPs have also been shown to un-
dergo multimerisation and this is thought to play an important
part in their repressive function (reviewed in [31]). Our data,
therefore, further support a role for ElrB, rather than ElrA,
in the translational repression of the Xenopus Vg1 mRNA.
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